We are committed to providing new and innovative ways to diagnose and treat patients through our diversified portfolio.
Our patient centered approach to rational drug development is supported by a clinical stage pipeline.
We aim to transform the lives of patients with neurological and psychiatric disorders through our next-generation therapeutics pipeline and imaging software device.
Parkinson’s Disease, Dementia with Lewy Bodies, Alzheimer’s Disease, Multiple System Atrophy, Essential Tremor.
Chronic Traumatic Encephalitis: Football, Soccer, Boxing, Hockey
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Acute Psychosis